Priority Date: 01.02.12 (KR 20120010462)

VECTOR SIMULTANEOUSLY EXPRESSING DODECAMERIC TRAIL AND HSV-TK SUICIDE GENES, AND ANTICANCER STEM CELL THERAPEUTIC AGENT USING SAME

  • Application ID: EP13743799
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Transfer Office

Attorney

no operation time available
Headquarter in Vienna
active in Legal Services and Matchmaking and Trading

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Redl Life Science Patent Attorneys is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 170 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 01.02.2012 - Priority Date (KR 20120010462)
  • 08.08.2013 - Publication A1 (WO2013115608)
  • 10.12.2014 - Publication A1 (EP2811023)